Unlocking Novel Chemistry
Designing Better Therapeutics

Ansaris was established in February 2009 to focus on small molecule drug discovery challenges, by leveraging 10 years of drug discovery expertise:

• Fragment-based drug design technology from Sarnoff Corporation
• Protein modeling technology from Protein Mechanics, Inc
• Evolution of technologies into next generation and advancement of drug candidates into development from Locus Pharmaceuticals